Form EFFECT Kailera Therapeutics,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 16, 2026 4:00 P.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- GIIB Sovereign Fund Management Partner and TripleX Global to Place Decentralized Sovereign Data Nodes — with On-Device AI and POS Terminals — Inside Merchant Businesses Across Korea in a 20-Year P
- KBRA Assigns Preliminary Ratings to SMRT 2026-MINI
- Intrepid Fiber Networks Completes Acquisition of Ubiquity’s Southern California Fiber Network
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
